Zilfou JT[au] - Search Results

Year	Number of Results
1995	4
1999	1
2000	1
2001	3
2002	1
2003	1
2004	1
2005	2
2006	2
2007	1
2008	3
2009	3
2024	0

1

Zilfou JT, Lowe SW. Zilfou JT, et al. Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a001883. doi: 10.1101/cshperspect.a001883. Cold Spring Harb Perspect Biol. 2009. PMID: 20066118 Free PMC article. Review.

2

Suppression of tumorigenesis by the p53 target PUMA.

Hemann MT, Zilfou JT, Zhao Z, Burgess DJ, Hannon GJ, Lowe SW. Hemann MT, et al. Among authors: zilfou jt. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9333-8. doi: 10.1073/pnas.0403286101. Epub 2004 Jun 10. Proc Natl Acad Sci U S A. 2004. PMID: 15192153 Free PMC article.

3

Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.

Smith CD, Myers CB, Zilfou JT, Smith SN, Lawrence DS. Smith CD, et al. Among authors: zilfou jt. Oncol Res. 2000;12(5):219-29. doi: 10.3727/096504001108747710. Oncol Res. 2000. PMID: 11417747

4

Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.

Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW. Dickins RA, et al. Among authors: zilfou jt. Nat Genet. 2005 Nov;37(11):1289-95. doi: 10.1038/ng1651. Epub 2005 Oct 2. Nat Genet. 2005. PMID: 16200064

5

Slugging it out: fine tuning the p53-PUMA death connection.

Zilfou JT, Spector MS, Lowe SW. Zilfou JT, et al. Cell. 2005 Nov 18;123(4):545-8. doi: 10.1016/j.cell.2005.11.003. Cell. 2005. PMID: 16286002 Free PMC article.

6

The ARF tumor suppressor can promote the progression of some tumors.

Humbey O, Pimkina J, Zilfou JT, Jarnik M, Dominguez-Brauer C, Burgess DJ, Eischen CM, Murphy ME. Humbey O, et al. Among authors: zilfou jt. Cancer Res. 2008 Dec 1;68(23):9608-13. doi: 10.1158/0008-5472.CAN-08-2263. Cancer Res. 2008. PMID: 19047137 Free PMC article.

7

Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors.

Lawrence DS, Zilfou JT, Smith CD. Lawrence DS, et al. Among authors: zilfou jt. J Med Chem. 1999 Dec 2;42(24):4932-41. doi: 10.1021/jm980591s. J Med Chem. 1999. PMID: 10585203

8

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Hoffman WH, et al. Among authors: zilfou jt. J Biol Chem. 2002 Feb 1;277(5):3247-57. doi: 10.1074/jbc.M106643200. Epub 2001 Nov 19. J Biol Chem. 2002. PMID: 11714700 Free article.

9

Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases.

Smith CD, Zilfou JT. Smith CD, et al. Among authors: zilfou jt. J Biol Chem. 1995 Nov 24;270(47):28145-52. doi: 10.1074/jbc.270.47.28145. J Biol Chem. 1995. PMID: 7499304 Free article.

10

The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.

Bosco EE, Wang Y, Xu H, Zilfou JT, Knudsen KE, Aronow BJ, Lowe SW, Knudsen ES. Bosco EE, et al. Among authors: zilfou jt. J Clin Invest. 2007 Jan;117(1):218-28. doi: 10.1172/JCI28803. Epub 2006 Dec 7. J Clin Invest. 2007. PMID: 17160137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year